Farmaceutica R (RMAH) — Defensive Interval Ratio

Latest as of December 2025: 250 days

Farmaceutica R (RMAH) has a Defensive Interval Ratio of 250 days as of December 2025. Defensive assets of RON203.88 Million (cash RON-, short-term investments RON-, receivables RON203.88 Million) cover 250 days of daily cash needs of RON817.12K/day. Check RMAH tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

250 days
Days of operational coverage

Defensive Assets

RON203.88 Million
Cash + ST Investments + Receivables

Daily Cash Need

RON817.12K
Current Liabilities ÷ 365

Current Liabilities

RON298.25 Million
RON

Farmaceutica R Defensive Interval Ratio (2020–2025)

This chart shows how Farmaceutica R's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 250 days, meaning defensive assets of RON203.88 Million can fund 250 days of operations without new revenue. Also explore net asset momentum of Farmaceutica R to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Farmaceutica R (2020–2025)

The table below presents the year-by-year Defensive Interval Ratio for Farmaceutica R from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Farmaceutica R (RMAH) market capitalisation.

Year DIR (days) Defensive Assets (RON) Daily Cash Need Cash ST Investments Change (days)
2025 250 days RON203.88 Million RON817.12K/day RON- RON- ▼ -18 days
2024 268 days RON216.95 Million RON810.67K/day RON- RON- ▼ -13 days
2023 281 days RON184.26 Million RON656.04K/day RON- RON- ▼ -15 days
2022 295 days RON173.70 Million RON587.93K/day RON- RON- ▲ +17 days
2021 279 days RON137.63 Million RON493.99K/day RON- RON- ▼ -14 days
2020 293 days RON130.20 Million RON444.89K/day RON- RON-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)